Papaveretum

Papaveretum

Combination of
Morphine	Opioid analgesic
Papaverine	Antispasmodic
Codeine	Opioid analgesic
[[{{{component4}}}]]	? Class
[[{{{component5}}}]]	? Class
Clinical data
Trade names	Omnopon
ATC code	N02AA10 (WHO)
Identifiers
PubChem CID	24840907
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}

WikiDoc Resources for Papaveretum
Articles
Most recent articles on Papaveretum Most cited articles on Papaveretum Review articles on Papaveretum Articles on Papaveretum in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Papaveretum Images of Papaveretum Photos of Papaveretum Podcasts & MP3s on Papaveretum Videos on Papaveretum
Evidence Based Medicine
Cochrane Collaboration on Papaveretum Bandolier on Papaveretum TRIP on Papaveretum
Clinical Trials
Ongoing Trials on Papaveretum at Clinical Trials.gov Trial results on Papaveretum Clinical Trials on Papaveretum at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Papaveretum NICE Guidance on Papaveretum NHS PRODIGY Guidance FDA on Papaveretum CDC on Papaveretum
Books
Books on Papaveretum
News
Papaveretum in the news Be alerted to news on Papaveretum News trends on Papaveretum
Commentary
Blogs on Papaveretum
Definitions
Definitions of Papaveretum
Patient Resources / Community
Patient resources on Papaveretum Discussion groups on Papaveretum Patient Handouts on Papaveretum Directions to Hospitals Treating Papaveretum Risk calculators and risk factors for Papaveretum
Healthcare Provider Resources
Symptoms of Papaveretum Causes & Risk Factors for Papaveretum Diagnostic studies for Papaveretum Treatment of Papaveretum
Continuing Medical Education (CME)
CME Programs on Papaveretum
International
Papaveretum en Espanol Papaveretum en Francais
Business
Papaveretum in the Marketplace Patents on Papaveretum
Experimental / Informatics
List of terms related to Papaveretum

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Papaveretum (BAN) is a preparation containing a mixture of hydrochloride salts of opium alkaloids. Since 1993, papaveretum has been defined in the British Pharmacopoeia (BP) as a mixture of 253 parts morphine hydrochloride, 23 parts papaverine hydrochloride, and 20 parts codeine hydrochloride. It is commonly marketed to medical agencies under the trade name Omnopon.

Although the use of papaveretum is now relatively uncommon following the wide availability of single-component opiates and synthetic opioids (e.g. pethidine) it is still used to relieve moderate to severe pain and for pre-operative sedation. In clinical settings, papaveretum is usually administered to patients via subcutaneous, intramuscular or intravenous routes. Additionally, the morphine syrettes found in combat medical kits issued to military personnel actually contain omnopon.

Prior to 1993, papaveretum also contained noscapine, though this component was removed from the BP formulation due to the genotoxic potential of noscapine.